Elizabeth Bhatt - Jul 21, 2021 Form 4 Insider Report for Applied Molecular Transport Inc. (AMTI)

Signature
/s/ Brandon Hants Attorney-in-Fact for Elizabeth Bhatt
Stock symbol
AMTI
Transactions as of
Jul 21, 2021
Transactions value $
-$288,607
Form type
4
Date filed
7/22/2021, 07:59 PM
Next filing
Aug 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMTI Common Stock Options Exercise $41.5K +9K $4.61* 9K Jul 21, 2021 Direct
transaction AMTI Common Stock Sale -$242K -6.64K -73.78% $36.41* 2.36K Jul 21, 2021 Direct F1
transaction AMTI Common Stock Sale -$88.3K -2.36K -100% $37.43* 0 Jul 21, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMTI Stock Option (Right to Buy) Options Exercise $0 -9K -2.98% $0.00 293K Jul 21, 2021 Common Stock 9K $4.61 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.99, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.27 to $37.61, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 1/4th of the shares subject to the option became vested on the Exercise Date and 1/48th of the shares subject to the option vest monthly thereafter, provided that the reporting person is a service provider to the issuer on each such vest date.